Concepedia

Pavlo Garkaviy

PG

Statistics

Publications

5

Citations

231

H-Index

5

Active since

2022

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (Finland)

Karolinska Institutet

Turku University Hospital

Sahlgrenska University Hospital

Pavlo Garkaviy is an author at AstraZeneca (Sweden) specializing in medicine, cardiology, and pharmacology.

Publications per year

2022–2024

5

Publications

5

Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting

Vesa Anttila, Antti Saraste, Juhani Knuuti et al. · Molecular Therapy · 2022 · 89 citations · Full text

, , +16

Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results

Carolyn S.P. Lam, Lars H. Lund, Sanjiv J. Shah et al. · Journal of Cardiac Failure · 2023 · 64 citations · Full text

, , +17

Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF

Erik Michaëlsson, Lars H. Lund, Camilla Hage et al. · JACC Heart Failure · 2023 · 52 citations · Full text

, , +17

AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial

Rick B. Vega, Pavlo Garkaviy, Jane Knöchel et al. · Atherosclerosis · 2024 · 14 citations · Full text

, , +11

Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans

Chandrali Bhattacharya, Ann-Sofie Sandinge, Ryan A. Bragg et al. · Drug Metabolism and Disposition · 2023 · 12 citations · Full text

, , +17

1–5 of 5